| |
| |
|
| Insider
Information: |
Ruffo Frank |
| Relationship: |
Chief Financial Officer |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
201,883 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$238,222 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
201,883 |
|
|
| Total
Value |
$238,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -21.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aclaris Therapeutics, Inc. |
ACRS |
Chief Financial Officer |
2022-03-10 |
201,883 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-03-10 |
4 |
S |
$15.55 |
$199,335 |
D/D |
(12,823) |
201,883 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,297 |
214,706 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,050 |
206,409 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-02-09 |
4 |
S |
$12.66 |
$17,568 |
D/D |
(1,388) |
172,359 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,875 |
173,747 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-06-02 |
4 |
S |
$21.51 |
$325,383 |
D/D |
(15,037) |
169,872 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,189 |
184,909 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-04-26 |
4 |
AS |
$25.79 |
$705,228 |
D/D |
(27,339) |
151,720 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-04-23 |
4 |
AS |
$26.64 |
$799,660 |
D/D |
(30,000) |
179,059 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-04-22 |
4 |
AS |
$26.84 |
$805,218 |
D/D |
(30,000) |
209,059 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-03-02 |
4 |
D |
$23.25 |
$66,123 |
D/D |
(2,844) |
239,059 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,297 |
241,903 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,750 |
240,939 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
D |
$24.06 |
$176,432 |
D/D |
(7,333) |
233,606 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
D |
$21.35 |
$27,926 |
D/D |
(1,308) |
215,189 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,875 |
216,497 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
212,992 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
D |
$4.59 |
$1,698 |
D/D |
(370) |
212,622 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-06-01 |
4 |
D |
$1.32 |
$12,475 |
D/D |
(9,451) |
211,692 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,188 |
221,143 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
D |
$1.26 |
$9,024 |
D/D |
(7,162) |
187,955 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,750 |
195,117 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-02-03 |
4 |
D |
$1.28 |
$1,674 |
D/D |
(1,308) |
169,367 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,875 |
170,675 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-12-18 |
4 |
D |
$1.81 |
$644 |
D/D |
(356) |
166,800 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
